Manipal Health Q2 Results: Net profit falls 10% on higher finance costs and exceptional charge

Manipal Health Services reported a mixed set of results for the second quarter, with net profit declining by 10% to ₹270 crore. While total revenue grew by 37.3% to ₹3,399 crore, the company faced higher finance costs and an exceptional charge, which weighed on its bottom line. Despite the profit dip, its earnings before interest, taxes, depreciation, and amortization (EBITDA) improved by 29.8% to ₹872 crore, indicating operational leverage.

For investors, the key takeaway is the widening gap between revenue growth and profit growth. While the 37% jump in revenue is a positive sign of business expansion, the 10% drop in net profit suggests that rising expenses and one-time charges are eating into margins. This divergence highlights the importance of looking beyond top-line growth to understand the underlying health of the business.

Moving forward, investors should monitor the company's ability to control finance costs and manage exceptional items. The decline in EBITDA margin to 26% from 27% warrants attention, as sustained margin compression could impact long-term profitability. Keeping an eye on future quarters will help determine if this is a temporary blip or a sign of structural challenges.